Eswar Shankar
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
112
Citations
1,939
Est. group size
~12
Recurring co-author estimate
Active years
23
Publishing since 2004
Eswar Shankar's research centers on prostate cancer, especially treatment resistance and metabolic changes in castration-resistant disease, as well as the cognitive side effects of hormone-lowering (androgen deprivation) therapy. The work also touches on broader cancer biology topics such as epigenetic regulation (EZH2), obesity-related cancer risk, and biomarker discovery in bladder and breast cancers. This research would suit students interested in cancer therapy resistance, cancer-related metabolism, or the links between cancer treatments and cognitive/metabolic health.
Publication output has fluctuated over the past decade, peaking around 2020 (12 papers) and dipping in 2024, with a recent increase in 2025, suggesting a somewhat variable but ongoing publication pace.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Cognitive dysfunction: link between diabetes and Alzheimer's disease
Elsevier eBooks · 2025
- List of contributors
Elsevier eBooks · 2025
- Proteome-Based Plasma Biomarkers for Cognitive Dysfunction in an Androgen Deprivation Model
Molecular Neurobiology · 2025
- EZH2-mediated development of therapeutic resistance in cancer
Cancer Letters · 2024
- Obesity and lack of breastfeeding: a perfect storm to augment risk of breast cancer?
Frontiers in Oncology · 2024
- Abstract 4766: Androgen deprivation in mice is linked with cognitive impairment
Cancer Research · 2024
- Inhibition of Wnt/β‐catenin pathway overcomes therapeutic resistance to abiraterone in castration‐resistant prostate cancer
Molecular Carcinogenesis · 2023
- Development of a novel apigenin prodrug programmed for alkaline-phosphatase instructed self-inhibition to combat cancer
Journal of Biomolecular Structure and Dynamics · 2023
- Abstract 1451: Cognition-mediated transcriptomic signature associated with androgen deprivation therapy in prostate cancer
Cancer Research · 2023
- Metabolic Syndrome: Modern India\'s Biggest Botheration and Concern
Annals of SBV · 2023
- Increased cytokine gene expression and cognition risk associated with androgen deprivation therapy
The Prostate · 2022
- Abstract 5316: Risk of cognitive impairment associated with androgen deprivation therapy in prostate cancer
Cancer Research · 2022
- MP27-11 INCREASED CYTOKINE GENE EXPRESSION AND INFLAMMATORY MARKERS ASSOCIATED WITH ANDROGEN DEPRIVATION THERAPY
The Journal of Urology · 2022
- PD10-09 IDENTIFICATION OF A 3-GENE PANEL IN THE PREDICTION AND PROGNOSIS OF BLADDER CANCER
The Journal of Urology · 2022
- Abstract 5358: Involvement of solute carrier transporters SLC25A17 and SLC27A6 in metabolic reprograming of castration-resistant prostate cancer
Cancer Research · 2022
- Cancer Research×30
- The Journal of Urology×10
- Molecular Carcinogenesis×4
- Elsevier eBooks×4
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Asmaa El-Kenawi
Biochemistry, Genetics and Molecular Biology · Indiana University
- Lei Chen
Biochemistry, Genetics and Molecular Biology · Indiana University
- Faye Zheng
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Scott A. Crist
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Melissa A. Babcook
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile